Maladies Hémorragiques Constitutionnelles

2020

• Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies. Vayne C, Guéry EA, Charuel N, Besombes J, Lambert WC, Rollin J, Gruel Y, Pouplard C. J Thromb Haemost. 2020 Jan 29.
• [Therapeutic antibodies in hemostasis. From the past to the future]. Gruel Y, Kizlik-Masson C, Lenting P. Med Sci (Paris). 2019 Dec Epub 2020 Jan 6

2019

• Use of von Willebrand Factor Concentrate in Inherited von Willebrand Disease: How Often Is It Useful to Add Factor VIII? Drillaud N, Ardillon L, Ternisien C, Valentin JB, Fouassier M, Gillet B, Gruel Y, Sigaud M, Horvais V, Bene MC, Trossaërt M. Transfus Med Rev. 2019 Nov 1

• Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP). Susen S, Gruel Y, Godier A, Harroche A, Chambost H, Lasne D, Rauch A, Roullet S, Fontana P, Goudemand J, de Maistre E, Chamouard V, Wibaut B, Albaladejo P, Négrier C. Haemophilia. 2019 Sep

• Multicentre evaluation of CK Prest® for assaying plasma levels of factor IX fused with albumin (Idelvion® ). Pouplard C, Galinat H, Ternisien C, Blanc Jouvan F, De Maistre E, Duchemin J, Flaujac C, Hézard N, Grand F, Le Cam-Duchez V, Marlu R, Mourey G, Nedelec F, Pineau-Vincent F, Repesse Y, Stépanian A, Szymezak J, Voisin S, Voyer AL, Jeanpierre E, Lasne D; French Study Group on Laboratory Management of bleeding disorders (BIMHO group). Haemophilia. 2019 Sep

• Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study. Tiefenbacher S, Albisetti M, Baker P, Kappert G, Kitchen S, Kremer Hovinga JA, Pouplard C, Scholz U, Ternisien C, Borgvall C, Vicente T, Belyanskaya L, Walter O, Oldenburg J; Nuwiq Field Study Participating Laboratories. Haemophilia. 2019 Jul

• Frequency and Clinical Impact of Platelet Factor 4-Specific Antibodies in Patients Undergoing Extracorporeal Membrane Oxygenation. Vayne C, May MA, Bourguignon T, Lemoine E, Guery EA, Rollin J, Gruel Y, Pouplard C. Thromb Haemost. 2019 Jul

• Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review. Yu JK, Iorio A, Edginton AN; WAPPS co‐investigators. Collaborateur: Pr. Y. GRUEL Res Pract Thromb Haemost. 2019 May 20
• Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia. Kizlik-Masson C, Deveuve Q, Zhou Y, Vayne C, Thibault G, McKenzie SE, Pouplard C, Loyau S, Gruel Y, Rollin J. Blood. 2019 May 30
• Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.Desjonqueres A, Guillet B, Beurrier P, Pan-Petesch B, Ardillon L, Pineau-Vincent F, Sigaud M, Fouassier M, Ternisien C, Gillet B, Béné MC, Horvais V, Lienhart A, Trossaërt M. Br J Haematol. 2019 May;
• Etiology and Outcomes of Thrombotic Microangiopathies. Bayer G, von Tokarski F, Thoreau B, Bauvois A, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Buchler M, Vigneau C, Fakhouri F, Halimi JM. Clin J Am Soc Nephrol. 2019 Apr
• Fibronectin: a “double hit” modulator in HIT? Gruel Y, Rollin J. Blood. 2019 Feb 28
• Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR). Godier A, Garrigue D, Lasne D, Fontana P, Bonhomme F, Collet JP, de Maistre E, Ickx B, Gruel Y, Mazighi M, Nguyen P, Vincentelli A, Albaladejo P, Lecompte T; French Working Group on Perioperative Haemostasis (GIHP). Arch Cardiovasc Dis. 2019 Mar
• Factor VIII assays in treated hemophilia A patients. Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose. Ann Biol Clin (Paris). 2019 Feb
• Factor IX assays in treated hemophilia B patients. Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose. Ann Biol Clin (Paris). 2019 Feb